Synthesis of 5-[(4-phenylpiperazin-1-yl)methyl]pyrrolo-[2,3-d]pyrimidine derivatives as potential dopamine D4 receptor ligands

Journal of Heterocyclic Chemistry

Volumn 44, Issue 2, 2007, Pages 349-354

  Linz, Sabine ^a   Troschütz, Reinhard ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYLPIPERAZINE DERIVATIVE; 2 (DIMETHYLAMINO) 3,7 DIHYDRO 4H PYRROLO[2,3 DEXTRO]PYRIMIDIN 4 ONE; 2 (DIMETHYLAMINO) 5 [(DIMETHYLAMINO)METHYL] 6 METHYL 3,7 DIHYDRO 4H PYRROLO[2,3 DEXTRO]PYRIMIDIN 4 ONE; 2 (DIMETHYLAMINO) 6 METHYL 3,7 DIHYDRO 4H PYRROLO[2,3 DEXTRO]PYRIMIDIN 4 ONE; 2 (DIMETHYLAMINO) 6 METHYL 5 [(4 PHENYLPIPERAZINE 1 YL)METHYL] 3,7 DIHYDRO 4H PYRROLO[2,3 DEXTRO] PYRIMIDIN 4 ONE; 2 (DIMETHYLAMINO) 6 [[4 (4 METHOXYPHENYL)PIPERAZIN 1 YL]METHYL] 3,7 DIHYDRO 4H PYRROLO[2,3 DEXTRO]PYRIMIDIN 4 ONE; 2 DIMETHYLAMINO 5 [[4 (2 METHOXYPHENYL)PIPERAZIN 1 YL]METHYL] 6 METHYL 3,7 DIHYDRO 4H PYRROLO[2,3 DEXTRO]PYRIMIDIN 4 ONE; 2 DIMETHYLAMINO 6 [[4 (2 METHOXYPHENYL)PIPERAZIN 1 YL]METHYL] 6 METHYL 3,7 DIHYDRO 4H PYRROLO[2,3 DEXTRO]PYRIMIDIN 4 ONE; 2 DIMETHYLAMINO PYRROLO[2,3 DEXTRO]PYRIMIDINE; 4 CHLORO N,N,6 TRIMETHYL 7H PYRROLO[2,3 DEXTRO]PYRIMIDIN 2 AMINE; 5 [(4 PHENYLPIPERAZIN 1 YL)METHYL]PYRROLO[2,3 DEXTRO]PYRIMIDINE DERIVATIVE; 5 [[4 (2 CHLOROPHENYL)PIPERAZIN 1 YL]METHYL] 2 (DIMETHYLAMINO) 6 METHYL 3,7 DIHYDRO 4H PYRROLO[2,3 DEXTRO]PYRIMIDIN 4 ONE; 5 [[4 (3,4 DICHLOROPHENYL)PIPERAZIN 1 YL]METHYL] 2 (DIMETHYLAMINO) 6 METHYL 3,7 DIHYDRO 4H PYRROLO[2,3 DEXTRO]PYRIMIDIN 4 ONE; 5 [[4 (4 CHLOROPHENYL)PIPERAZIN 1 YL]METHYL] 2 (DIMETHYLAMINO) 6 METHYL 3,7 DIHYDRO 4H PYRROLO[2,3 DEXTRO]PYRIMIDIN 4 ONE; DOPAMINE 4 RECEPTOR; FORMALDEHYDE; LIGAND; MANNICH BASE; PHENYLPIPERAZINE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANNULATION REACTION; ARTICLE; DRUG SYNTHESIS;

EID: 36749055713     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570440211     Document Type: Article

References (31)

1. N. J. Hrib, Drugs of the Future, 25, 587 (2000).
2. P. Sokoloff, J. C. Schwartz, Trends Pharmacol. Sci., 16, 270 (1995).
3. D. R. Sibley; F. J. Monsma, Jr., Trends Pharmacol. Sci., 13, 61 (1992).
4. K. A. Neve, R. L. Neve, The Dopamine Receptors, Humana Press: Totowa, NJ, (1997).
5. K. L. Davis, R. S. Kahn, G. Ko, M. Davidson, Am. J. Psychiatry, 148, 1474 (1991).
6. P. Seeman, H. C. Guan, H. H. Van Tol, Nature, 365, 441 (1993).
7. J. J. Kulagowski, H. B. Broughton, N. R. Curtis; I. M. Mawer, M. P. Ridgill, R. Baker, F. Emms, S. B. Freedman, R. Marwood, S. Patel, C. I. Ragan, P. D. Leeson, J. Med. Chem., 39, 1941 (1996).
8. M. Rowley, H. B. Broughton, I. Collins; R. Baker, F. Emms, R. Marwood, S. Patel, C. I. Ragan, S. B. Freedman, P. D. Leeson, J. Med. Chem., 39, 1943 (1996).
9. M. Rowley, I. Collins, H. B. Broughton, W. B. Davey, R. Baker, F. Emms, R. Marwood, S. Patel, C. I. Ragan, S. B. Freedman, R. Ball, P. D. Leeson, J. Med. Chem., 40, 2374 (1997).
10. I. Boyfield, T. H. Brown, M. C. Coldwell, D. G. Cooper, M. S. Hadley, J. J. Hagan, M. A. Healy, A. Johns, R. J. King, D. N. Middlemiss, D. J. Nash, G. J. Riley, E. E. Scott, S. A. Smith, G. Stemp, J. Med. Chem., 39, 1946 (1996).
11. J. Ohmori, K. Maeno, K. Hidaka, K. Nakato, M. Matsumoto, S. Tada, H. Hattori, S. Sakamoto, S. Tsukamoto, S. Usuda, T. Mase, J. Med. Chem., 39, 2764 (1996).
12. P. C. Unangst, T. Capiris, D. T. Connor, T. G. Heffner, R. G. MacKenzie, S. R. Miller, T. A. Pugsley, L. D. Wise, J. Med. Chem., 40, 2688 (1997).
13. P. C. Unangst, T. Capiris, D. T. Connor, R. Doubleday, T. G. Heffner, R. G. MacKenzie, S. R. Miller, T. A. Pugsley, L. D. Wise, J. Med. Chem., 40, 4026 (1997).
14. S. Patel, S. Freedman, K. L. Chapman, F. Emms, A. E. Fletcher, M. Knowles, R. Marwood, G. McAllister, J. Myers, N. Curtis, J. J. Kulagowski, P. D. Leeson, M. Ridgill, M. Graham, S. Matheson, D. Rathbone, A. P. Watt, L. J. Bristow, N. M. Rupniak, E. Baskin, J. J. Lynch, C. I. Ragan, J. Pharmacol. Exp. Ther., 283, 636 (1997).
15. R. A. West, J. Org. Chem., 26, 4959 (1961).
16. F. Seela, U. Lüpke, Chem. Ber., 110, 1462 (1977).
17. H. Akimoto, E. Imamiya, T. Hitaka, H. Nomura, J. Chem. Soc., 1637 (1988).
18. K. J. M. Andrews, N. Anand, A. R. Todd, A. Topham, J. Chem. Soc., 2490 (1949).
19. A. Gangjee, J. Yu, R. L. Kisliuk, J. Heterocycl. Chem., 39, 833 (2002).
20. C. W. Noell, R. K. Robins, J. Heterocycl. Chem., 1, 34 (1964).
21. J. A. Secrist, P. S. Liu, J. Org. Chem., 43, 3937 (1978).
22. Lilly, Drugs Fut., 25, 528 (2000).
23. K. Ramasamy, R. K. Robins, G. R. Revankar, J. Chem. Soc. Chem. Commun., 9, 560 (1989).
24. M. L. Quijano, M. Nogueras, A. Sanchez, G. Alvarez de Cienfuegos, M. Melgarejo, J. Heterocycl. Chem., 27, 1079 (1990).
25. A. Gangjee, Y. Zeng, J. J. McGuire, R. L. Kisliuk, J. Med. Chem., 48, 5329 (2005).
26. R. Baker, N. Curtis, J. J. Kulagowski, P. D. Leeson, M. Ridgill, A. L. Smith, WO 9420497, (1994).
27. F. Seela, H. Steker, Liebigs Ann. Chem., 1719 (1984).
28. H. Hübner, C. Haubmann, W. Utz, P. Gmeiner, J. Med. Chem., 43, 756 (2000).
29. G. Hayes, T. J. Biden, L. A. Selbie, J. Shine, Mol. Endocrinol., 6, 920 (1992).
30. P. Sokoloff, M. Andrieux, R. Besançon, C. Pilon, M.-P. Martres, B. Giros, J.-C. Schwartz, Eur. J. Pharmacol., 225, 331 (1992).
31. V. Asghari, S. Sanyal, S. Buchwaldt, A. Paterson, V. Jovanovic, H. H. M. Van Tol, J. Neurochem., 65, 1157 (1995).